Womens health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications, announced the closing of a $19.3M financing led by InterWest, Domain Associates and Catalyst Health Ventures. Also participating in the round are the company's founder, UpStart Life Sciences Capital, and new investor Osage University Partners.
more...